ALACHUA, Fla., Jan. 29 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (Amex: TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the first quarter ended December 31, 2007 on Wednesday, February 6, 2008. The Company will discuss these results in a conference call scheduled for 10:00 a.m. ET, on February 6, 2008.
Interested parties can access the call by dialing (888) 408-9532 or (706) 679-5064 or by accessing the web cast at http://www.tutogen.com/Investor.aspx. A replay of the call will be available at (800) 642-1687 or (706) 645-9291, conference ID number: 33119197 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/Investor.aspx for 30 days.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products
made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes
its proprietary Tutoplast Process(R) of tissue preservation and viral
inactivation to manufacture and deliver sterile bio-implants used in
spinal/trauma, urology, dental, ophthalmology, and general surgery
procedures. The Company's Tutoplast(R) products are sold and distributed
worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer
Holdings, Inc., Davol Inc., a subsidiary of C.R. Bard Inc., the Mentor
Corporation, Coloplast Corp., IOP, Inc. and through independent
distributors internationally. For more information, visit the Company's web
site at http://www.tutogen.com.
L. Robert Johnston, Jr. Lytham Partners, LLC
Chief Financial Officer Joe Diaz
Tutogen Medical, Inc. Joe Dorame
386-462-0402 Robert Blum
|SOURCE Tutogen Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved